These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 8191452)

  • 1. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
    Hatlebakk JG; Berstad A
    Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Results of the treatment of gastroesophageal reflux and peptic esophagitis using cisapride].
    Carrasco Gandía S; Lama Moré R; Prieto Bozano G; Polanco Allue I
    An Esp Pediatr; 1990 Jun; 32(6):485-8. PubMed ID: 2221622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cisapride efficacy in gastroesophageal reflux in children].
    Bottaro G; Rotolo N; Spina M; Azzaro F; Galletta C; Romano D; Castiglione N; Patanè R
    Pediatr Med Chir; 1993; 15(2):141-4. PubMed ID: 8321715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current status of gastric prokinetic drugs.
    Schapira M; Henrion J; Heller FR
    Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of gastro-oesophageal reflux and gastric stasis: new perspectives with cisapride. Proceedings of a symposium of the 13th International Congress of Gastroenterology. Rome, 6 September 1988.
    Scand J Gastroenterol Suppl; 1989; 165():1-65. PubMed ID: 2602909
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacologic and clinical differentiation of prokinetic drugs].
    May B; Greving I
    Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prokinetic drugs in digestive disorders].
    Carella G; Marra L
    Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisapride: influence on oesophageal and gastric emptying and gastro-oesophageal reflux in patients with reflux oesophagitis.
    Collins BJ; Spence RA; Ferguson R; Laird J; Love AH
    Hepatogastroenterology; 1987 Jun; 34(3):113-6. PubMed ID: 3301606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cisapride on parameters of oesophageal motility and on the prolonged intraoesophageal pH test in infants with gastro-oesophageal reflux disease.
    Cucchiara S; Staiano A; Boccieri A; De Stefano M; Capozzi C; Manzi G; Camerlingo F; Paone FM
    Gut; 1990 Jan; 31(1):21-5. PubMed ID: 2180792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A drive substance for the motor in digestion. Introduction].
    Demling L
    Fortschr Med Suppl; 1990; 87():4. PubMed ID: 2351358
    [No Abstract]   [Full Text] [Related]  

  • 12. Prokinetic therapy for gastroesophageal reflux disease.
    Robinson M
    Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cisapride: its use in children.
    Newell SJ
    Br J Hosp Med; 1990 Dec; 44(6):408-9. PubMed ID: 2081312
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of chronic-obstructive upper abdominal complaints. Outlook. Further hypothetical indications].
    Fortschr Med Suppl; 1990; 87():15-6. PubMed ID: 2190899
    [No Abstract]   [Full Text] [Related]  

  • 15. Cisapride.
    Molinari F; Farrington E
    Pediatr Nurs; 1994; 20(2):202-3. PubMed ID: 8159508
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisapride in gastro-oesophageal reflux disease: effects on oesophageal motility and intra-oesophageal pH.
    Wienbeck M; Li Q
    Scand J Gastroenterol Suppl; 1989; 165():13-8; discussion 27-8. PubMed ID: 2690320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
    Ramirez B; Richter JE
    Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastroesophageal reflux disease: pathophysiology and pharmacology overview.
    Dajani EZ
    J Assoc Acad Minor Phys; 2000; 11(1):7-11. PubMed ID: 10826019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of delayed gastric emptying and impaired oesophageal body motility.
    Penagini R; Bravi I
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):831-45. PubMed ID: 21126697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prokinetic drugs].
    Hellström P
    Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.